NCT02133404View on ClinicalTrials.gov

A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 14, 2014

Primary Completion Date

November 10, 2014

Study Completion Date

November 10, 2014

Conditions
Secondary Hyperparathyroidism
Interventions
DRUG

ASP7991

oral

DRUG

Cinacalcet

oral

DRUG

Placebo

oral

Trial Locations (6)

Unknown

Chugoku

Chūbu

Kanto

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY